John EvansMay 21, 20212 minNew oral JAK inhibitor effective for moderate-to-severe ADRecently published findings from clinical trials of the oral Janus kinase (JAK) inhibitor upadacitinib show it is highly effective in...
John EvansDec 11, 20202 minPsoriasis biologic clinical trial findings confirmed by study of real-world dataA study of real-world data has shown that the relative difference in efficacy of secukinumab compared to ustekinumab used for psoriasis...